Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 77, 2017 - Issue 4
Submit an article Journal homepage
198
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Comparison of methods for estimating glomerular filtration rate in head and neck cancer patients treated with cisplatin

Lotte LindbergDepartment of Clinical Physiology and Nuclear Medicine, Herlev Hospital, University of Copenhagen, Herlev, Denmark; Correspondence[email protected]
,
Kasper BrødbækDepartment of Clinical Physiology and Nuclear Medicine, Herlev Hospital, University of Copenhagen, Herlev, Denmark; ;Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;
,
Erik G. HägerströmDepartment of Otorhinolaryngology, Head and Neck Surgery, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;
,
Jens BentzenDepartment of Oncology, Herlev Hospital, University of Copenhagen, Herlev, Denmark
,
Bent KristensenDepartment of Clinical Physiology and Nuclear Medicine, Herlev Hospital, University of Copenhagen, Herlev, Denmark;
&
Bo ZerahnDepartment of Clinical Physiology and Nuclear Medicine, Herlev Hospital, University of Copenhagen, Herlev, Denmark;
Pages 237-246 | Received 04 Oct 2016, Accepted 18 Feb 2017, Published online: 20 Mar 2017

References

  • Oh GS, Kim HJ, Shen A, Lee SB, Khadka D, Pandit A, So HS. Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies. Electrolyte Blood Press 2014;12:55–65.
  • Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008;73:994–1007.
  • Driessen CM, Uijen MJ, van der Graaf WT, van Opstal CC, Kaanders JH, Nijenhuis T, van Herpen CM. Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer. Head Neck 2016;38:E1575–81.
  • Aass N, Fossa SD, Aas M, Lindegaard MW. Renal function related to different treatment modalities for malignant germ cell tumours. Br J Cancer 1990;62:842–6.
  • Bhat ZY, Cadnapaphornchai P, Ginsburg K, Sigvagnanam M, Chopra S, Treadway CK, Lin HS, Yoo G, Sukari A, Doshi MD. Understanding the risk factors and long-term consequences of cisplatin-associated acute kidney injury: an observational cohort study. PLoS One 2015;10:e0142225.
  • Filler G, Yasin A, Medeiros M. Methods of assessing renal function. Pediatr Nephrol 2014;29:183–92.
  • Brochner-Mortensen J, Giese J, Rossing N. Renal inulin clearance versus total plasma clearance of 51Cr-EDTA. Scand J Clin Lab Invest 1969;23:301–5.
  • Granerus G, Aurell M. Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate. Scand J Clin Lab Invest 1981;41:611–16.
  • Brochner-Mortensen J, Rodbro P. Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 1976;36:35–43.
  • Hudson JQ, Nyman HA. Use of estimated glomerular filtration rate for drug dosing in the chronic kidney disease patient. Curr Opin Nephrol Hypertens 2011;20:482–91.
  • Pottel H. Critical review of method comparison studies for the evaluation of estimating glomerular filtration rate equations. Int J Nephrol Kidney Failure 2015;1. doi: 10.16966/2380-5498.102
  • Bentzen J, Toustrup K, Eriksen JG, Primdahl H, Andersen LJ, Overgaard J. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study. Acta Oncol 2015;54:1001–7.
  • Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649–55.
  • Groth S, Aasted M, Vestergaard B. Screening of kidney function by plasma creatinine and single-sample 51Cr-EDTA clearance determination – a comparison. Scand J Clin Lab Invest 1989;49:707–10.
  • Brochner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 1972;30:271–4.
  • Groth S, Aasted M. 51Cr-EDTA clearance determined by one plasma sample. Clin Physiol 1981;1:417–25.
  • Groth S, Aasted M. Determination of 51Cr-EDTA clearance between 15 and 40 ml/min/1.73 m2 by a single plasma sample. Scand J Clin Lab Invest 1989;49:711–17.
  • Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, III, Feldman HI, Kusek JW, Eggers P, Van LF, Greene T, Coresh JA. New equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604–12.
  • Funakoshi Y, Fujiwara Y, Kiyota N, Mukohara T, Shimada T, Toyoda M, Imamura Y, Chayahara N, Tomioka H, Umezu M, Otsuki N, Nibu K, Minami H. Validity of new methods to evaluate renal function in cancer patients treated with cisplatin. Cancer Chemother Pharmacol 2016;77:281–8.
  • DuBois D, DuBois EF. Formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916;17:863–71.
  • Fox J, Weisberg S. An R companion to applied regression. 2nd ed. Thousand Oakes (CA): SAGE; 2011.
  • Yoshida K, Bohn J. Tableone: create ‘Table 1’ to describe baseline characteristics. 2015. Available from: https://CRAN.R-project.org/package=tableone
  • Carstensen B. Comparing clinical measurement methods: a practical guide. Chichester, UK: John Wiley & Sons Ltd; 2010.
  • Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–10.
  • Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clinical Chemistry 1992;38:1933–53.
  • Redal-Baigorri B, Stokholm KH, Rasmussen K, Jeppesen N. Estimation of kidney function in cancer patients. Dan Med Bull 2011;58:A4236.
  • Bostom AG, Kronenberg F, Ritz E. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol 2002;13:2140–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.